---
title: 'Funding Daily Summary: What Happened on November 3, 2026'
headline: BioInnovation Institute expands cardiometabolic initiative to Germany
description: The European CardioMetabolic Bridge will add Munich and Berlin, with
  up to DKK 450 million in foundation backing over six years.
url: https://thebench.bio/news/funding/2026-11-03
topic: funding
date: '2026-11-03'
covers:
- '2026-11-03'
date_published: '2026-11-03T12:01:31Z'
date_modified: '2026-11-03T12:01:31Z'
tags:
- Industry
sources: 1
publisher: TheBench.Bio
---

# Funding Daily Summary: What Happened on November 3, 2026

**BioInnovation Institute expands cardiometabolic initiative to Germany**

The European CardioMetabolic Bridge will add Munich and Berlin, with up to DKK 450 million in foundation backing over six years.

## Today in brief

BioInnovation Institute plans to expand its European CardioMetabolic Bridge from London to Munich and Berlin. [1] The Novo Nordisk Foundation is providing up to DKK 450 million over six years for the initiative, which aims to move academic cardiometabolic research toward drug development and company formation. [1]

## The day in numbers

- **Up to DKK 450 million over six years**: Novo Nordisk Foundation backing for the European CardioMetabolic Bridge expansion. [1]

## Sources

1. [Danish BioInnovation Institute builds a bridge to Germany](<https://european-biotechnology.com/latest-news/danish-bioinnovation-institute-builds-a-bridge-to-germany/>), European Biotechnology, 2026-11-03

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://european-biotechnology.com/latest-news/danish-bioinnovation-institute-builds-a-bridge-to-germany/>